AA
AlphaCentric Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,000
| Closed | -$341K | – | 285 |
|
|
2024
Q3 | $341K | Buy |
15,000
+2,500
| +20% | +$56.9K | 0.25% | 102 |
|
|
2024
Q2 | $163K | Buy |
12,500
+6,500
| +108% | +$84.6K | 0.12% | 137 |
|
|
2024
Q1 | $105K | Buy |
+6,000
| New | +$105K | 0.06% | 186 |
|
|
2023
Q4 | – | Sell |
-80,000
| Closed | -$1.23M | – | 285 |
|
|
2023
Q3 | $1.23M | Buy |
80,000
+44,500
| +125% | +$683K | 0.7% | 47 |
|
|
2023
Q2 | $845K | Hold |
35,500
| – | – | 0.47% | 75 |
|
|
2023
Q1 | $903K | Hold |
35,500
| – | – | 0.62% | 58 |
|
|
2022
Q4 | $1.04M | Hold |
35,500
| – | – | 1.02% | 34 |
|
|
2022
Q3 | $728K | Buy |
+35,500
| New | +$728K | 0.75% | 45 |
|